Latest / Cleveland Clinic Cancer Advances
Predicting Survival using Genomic Adjusted Radiation Dose
Jacob Scott, MD, DPhil, radiation oncologist, associate professor, and staff physician-scientist at Cleveland Clinic, joins the Cancer Advances podcast to talk about the research he presented at the American Society of Radiation Oncology (ASTRO) 2022 Annual Meeting. Listen as Dr. Scott discusses preliminary results from a recent Cleveland Clinic study about using GARD to predict overall survival in patients with HPV positive oropharyngeal squamous cell carcinoma treated with radiotherapy.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.